Scientists have identified a molecular switch that may help explain how colorectal cancer becomes deadly. When levels of a ...
6d
VERAXA Biotech (NASDAQ: VRXA) Initiates Cell Line Development for Lead BiTAC Cancer Therapy Program
VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...
A new platform developed by researchers at the University of Texas MD Anderson Cancer Center quickly finds and isolates rare, ...
Scientists have identified a molecular switch that may explain how colorectal cancer becomes more aggressive. The discovery ...
Scientists at USC have developed a way to create a renewable supply of immune cell precursors that can be grown in large ...
Getting it over the finish line was a labor of love—and now, more than five years after her death, the lab of former Sloan ...
Our bodies are constantly deciding which cells should live and which should die through a process called apoptosis. This type ...
Confluence Genetics today announced the launch of Cas-CLEAR™, Collaterally Enhanced Activated Ribonuclease, a new CRISPR technology plat ...
InxMed Co., Ltd ("InxMed"), a clinical-stage biotechnology company dedicated to developing innovative therapies targeting cancer treatment resistance and metastasis, today announced that the clinical ...
Scientists have discovered that creatine may strengthen one of the immune system's most important cancer-fighting pathways by energizing dendritic cells that activate killer T cells. The promising ...
Scientists have identified a promising new strategy to tackle one of the biggest obstacles in treating glioblastoma, one of the most aggressive forms of brain cancer: resistance to chemotherapy. The ...
Hiroshima University researchers have demonstrated a proof of concept for the mass production of genome-edited T cells that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results